VANI — Vivani Medical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Vivani Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.92 | -13.9 | -25.7 | -23.5 | -26.6 |
| Depreciation | |||||
| Non-Cash Items | 0.084 | -5.62 | 2.89 | 1.69 | 1.24 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.421 | 0.338 | -1.29 | 0.607 | 0.63 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -9.19 | -18.8 | -23.7 | -20.8 | -24.3 |
| Capital Expenditures | -0.014 | -0.338 | -0.887 | -0.556 | -1.17 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.014 | -0.338 | -0.887 | -0.556 | -1.17 |
| Financing Cash Flow Items | 0.002 | 8 | — | 0.237 | 0.011 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 75.6 | 63.4 | 0.133 | 19.1 | 23.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 66.4 | 44.3 | -24.4 | -2.3 | -2.12 |